Covovax gets DCGI’s EUA nod for 12-17-year-olds

In a move that will further expand the basket of Covid vaccines approved for adolescents, the drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in 12-17 year olds. This is the fourth vaccine to get regulatory approval for use in youngsters.

from Times of India https://ift.tt/6RltxIv
https://ift.tt/BLU78xn March 10, 2022 at 01:27AM

Comments

Popular posts from this blog

Covid live: Record 50,000+ infections on Sunday

Impact of pandemic? Women jobseekers fell by 34% in 2021

SC slams trial courts for seeking needless custody